Change in Management

Emcure Ref: EPL/CS/SE/0053/2026 Date: June 30, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Senior Management Personnel of the Company Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we hereby inform that Mr. Kuber Jagdale, President – API Business, superannuates from his employment with the Company with effect from close of business hours on June 30, 2026 and consequently ceases to be a Senior Management Personnel of the Company as per Regulation 16(1)(d) of the SEBI Listing Regulations. This cessation is on account of superannuation and does not constitute a resignation; accordingly, submission of a resignation letter is not applicable in this case. The particulars of the disclosure required under Regulation 30 and Part A of Schedule III of the SEBI Listing Regulations are provided in Annexure A, enclosed herewith. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer Membership Number: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251 Emcure Annexure - A Disclosure under Para (A) of Part (A) of Schedule III to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Sr. Particulars Information 1 Reason for change viz. Superannuation appointment, re-appointment, resignation, removal, death or otherwise 2 Date of appointment/ C e s s a t i o n w ith effect from close of business hours on re-appointment/cessation (as June 30, 2026 applicable) & term of appointment/re-appointment 3 Brief profile Not Applicable (in case of appointment); 4 Disclosure of relationships Not Applicable between Directors (in case of appointment of a director). Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251